A DR4, DR5 Targeting Conjugated TRAIL Treatment for Colorectal Carcinogenesis: A Way to Future?
A DR4, DR5 Targeting Conjugated TRAIL Treatment for Colorectal Carcinogenesis: A Way to Future?
About this item
Full title
Author / Creator
Publisher
Tabriz: Tabriz University of Medical Sciences
Journal title
Language
English
Formats
Publication information
Publisher
Tabriz: Tabriz University of Medical Sciences
Subjects
More information
Scope and Contents
Contents
TRAIL or tumor necrosis factor-related apoptosis-inducing ligand has been one of the major frontiers for the chemotherapeutic approach to treating carcinogenesis. Despite the emergence of TRAIL resistance cancer cell lines, it has been extensively studied for its unique property to induce apoptosis and provide specificity to any other conjugated ch...
Alternative Titles
Full title
A DR4, DR5 Targeting Conjugated TRAIL Treatment for Colorectal Carcinogenesis: A Way to Future?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3199837144
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3199837144
Other Identifiers
ISSN
1735-403X
E-ISSN
2383-2886
DOI
10.34172/PS.024.40334
